Raleigh, NC, United States of America

Pritha Agarwalla

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: North Carolina State University, The University of North Carolina at Chapel Hill. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pritha Agarwalla: Innovator in Viral Transduction Technologies

Introduction

Pritha Agarwalla is a notable inventor based in Raleigh, NC (US). She has made significant contributions to the field of viral transduction, particularly in enhancing the efficiency of mammalian cell transduction. Her innovative work has implications for various applications in biotechnology and medicine.

Latest Patents

Pritha Agarwalla holds a patent titled "Enhanced viral transduction of mammalian cells using material scaffolds." This patent discloses compositions and methods for a low-cost, tunable, macroporous alginate scaffold that effectively transduces T cells with vectors under static conditions. This advancement represents a significant step forward in the field of cellular engineering.

Career Highlights

Throughout her career, Pritha has worked with esteemed institutions such as North Carolina State University and the University of North Carolina at Chapel Hill. Her experience in these research environments has allowed her to develop and refine her innovative ideas.

Collaborations

Pritha has collaborated with notable professionals in her field, including Yevgeny Brudno and Gianpietro Dotti. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Pritha Agarwalla's work in enhancing viral transduction technologies showcases her innovative spirit and dedication to advancing biotechnology. Her contributions are paving the way for future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…